Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis - Gastroenterology
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
Exabis Library:
Biomedicines | Free Full-Text | Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis? - ScienceDirect
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study - Clinical Nutrition ESPEN
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
Definition of remission of ra | PPT
IBD treatment plan 'needs to be a continuous conversation'
Frontiers | Monitoring of patients with active inflammatory bowel disease
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis
The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports
ECCO
Remission endpoints in ulcerative colitis: A systematic review
Efficacy Data | SKYRIZI® (risankizumab-rzaa)
Efficacy - RINVOQ® (upadacitinib) for Ulcerative Colitis
Ulcerative Colitis (UC): Efficacy | STELARA® (ustekinumab) HCP
![available as Supplementary data at ECCO-JCC online]. | Download Table](https://www.researchgate.net/publication/289686991/figure/tbl1/AS:667881423507459@1536246748177/available-as-Supplementary-data-at-ECCO-JCC-online.png "available as Supplementary data at ECCO-JCC online]. | Download Table")
available as Supplementary data at ECCO-JCC online]. | Download Table
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease - The Lancet Gastroenterology & Hepatology
How Do We Treat Inflammatory Bowel Diseases to Aim For Endoscopic Remission? - ScienceDirect
Serum biomarkers confirming stable remission in inflammatory bowel disease | Scientific Reports
